These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 6365804

  • 1. Decreased removal of triglycerides from the blood--a mechanism for the hypertriglyceridemia in male patients with coronary artery disease.
    Tollin C, Ericsson M, Johnson O, Backman C, Jacobsson KA, Osterman G, Billström A.
    Int J Cardiol; 1984 Feb; 5(2):185-94. PubMed ID: 6365804
    [Abstract] [Full Text] [Related]

  • 2. Comparative serum apolipoprotein studies in ischaemic heart disease and control subjects.
    Onitiri AC, Jover E.
    Clin Chim Acta; 1980 Nov 20; 108(1):25-30. PubMed ID: 7470245
    [Abstract] [Full Text] [Related]

  • 3. Serum lipoproteins, apolipoproteins and intravenous fat tolerance in young athletes.
    Ericsson M, Johnson O, Tollin C, Furberg B, Backman C, Angquist K.
    Scand J Rehabil Med; 1982 Nov 20; 14(4):209-12. PubMed ID: 7178868
    [Abstract] [Full Text] [Related]

  • 4. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency.
    Angquist KA, Johnson O, Ericsson M, Tollin C.
    Acta Chir Scand; 1982 Nov 20; 148(8):675-8. PubMed ID: 6820598
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease.
    Nieminen MS, Mattila KJ, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen MR.
    Arterioscler Thromb; 1992 Jan 20; 12(1):58-69. PubMed ID: 1346250
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ, Mitropoulos KA, Venkatesan S, Watts GF, Reeves BE, Halliday D.
    Atherosclerosis; 1993 Nov 20; 103(2):231-43. PubMed ID: 8292098
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Severity of coronary atherosclerosis related to lipoprotein concentration.
    Jenkins PJ, Harper RW, Nestel PJ.
    Br Med J; 1978 Aug 05; 2(6134):388-91. PubMed ID: 210876
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM, Watts GF, Sprecher DL, Chan DC, Barrett PH.
    J Clin Endocrinol Metab; 2011 Oct 05; 96(10):E1568-76. PubMed ID: 21816786
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum lipid and lipoprotein concentrations in chronic uremia.
    Norbeck HE, Orö L, Carlson LA.
    Acta Med Scand; 1976 Oct 05; 200(6):487-92. PubMed ID: 189577
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.